Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer

被引：227

作者：

Davids, Matthew S. ^{[1
]}

Letai, Anthony ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02215 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 25期

关键词：

CHRONIC LYMPHOCYTIC-LEUKEMIA; BCL-2 ANTISENSE OLIGONUCLEOTIDE; ACUTE MYELOID-LEUKEMIA; BH3 MIMETIC ABT-737; PHASE-I; CHROMOSOME-TRANSLOCATION; MITOCHONDRIAL-MEMBRANE; OBLIMERSEN SODIUM; CYTOCHROME-C; OBATOCLAX MESYLATE;

D O I：

10.1200/JCO.2011.37.0981

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The B-cell lymphoma/leukemia 2 (BCL-2) family of proteins has attracted the attention of cancer biologists since the cloning of BCL-2 more than 25 years ago. In the intervening decades, the way the BCL-2 family controls commitment to programmed cell death has been greatly elucidated. Several drugs directed at inhibiting BCL-2 and related antiapoptotic proteins have been tested clinically, with some showing considerable promise, particularly in lymphoid malignancies. A better understanding of the BCL-2 family has also provided insight into how conventional chemotherapy selectively kills cancer cells and why some cancers are more chemosensitive than others. Further exploitation of our understanding of the BCL-2 family promises to offer improved predictive biomarkers for oncologists and improved therapies for patients with cancer. J Clin Oncol 30: 3127-3135. (C) 2012 by American Society of Clinical Oncology

引用

页码：3127 / 3135

页数：9

共 72 条

[1] An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737
Al-Harbi, Sayer
Hill, Brian T.
Mazumder, Suparna
Singh, Kamini
DeVecchio, Jennifer
Choudhary, Gaurav
Rybicki, Lisa A.
Kalaycio, Matt
Maciejewski, Jaroslaw P.
Houghton, Janet A.
Almasan, Alexandru
[J]. BLOOD, 2011, 118 (13) : 3579 - 3590
[2] Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria
Antonsson, B
Montessuit, S
Lauper, S
Eskes, R
Martinou, JC
[J]. BIOCHEMICAL JOURNAL, 2000, 345 : 271 - 278
[3] Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients
Badros, A
Goloubeva, O
Rapoport, AP
Ratterree, B
Gahres, N
Meisenberg, B
Takebe, N
Heyman, M
Zwiebel, J
Streicher, H
Gocke, CD
Tomic, D
Flaws, JA
Zhang, B
Fenton, RG
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) : 4089 - 4099
[4] CLONING THE CHROMOSOMAL BREAKPOINT OF T(14-18) HUMAN LYMPHOMAS - CLUSTERING AROUND JH ON CHROMOSOME-14 AND NEAR A TRANSCRIPTIONAL UNIT ON 18
BAKHSHI, A
JENSEN, JP
GOLDMAN, P
WRIGHT, JJ
MCBRIDE, OW
EPSTEIN, AL
KORSMEYER, SJ
[J]. CELL, 1985, 41 (03) : 899 - 906
[5] Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: The oblimersen melanoma study group
Bedikian, Agop Y.
Millward, Michael
Pehamberger, Hubert
Conry, Robert
Gore, Martin
Trefzer, Uwe
Pavlick, Anna C.
DeConti, Ronald
Hersh, Evan M.
Hersey, Peter
Kirkwood, John M.
Haluska, Frank G.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) : 4738 - 4745
[6] Inhibition of potentially anti-apoptotic proteins by antisense protein kinase C-α (Isis 3521) and antisense bcl-2 (G3139) phosphorothioate oligodeoxynucleotides:: Relationship to the decreased viability of T24 bladder and PC3 prostate cancer cells
Benimetskaya, L
Miller, P
Benimetsky, S
Maciaszek, A
Guga, P
Beaucage, SL
Wilk, A
Grajkowski, A
Halperin, AL
Stein, CA
[J]. MOLECULAR PHARMACOLOGY, 2001, 60 (06) : 1296 - 1307
[7] BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH
BOISE, LH
GONZALEZGARCIA, M
POSTEMA, CE
DING, LY
LINDSTEN, T
TURKA, LA
MAO, XH
NUNEZ, G
THOMPSON, CB
[J]. CELL, 1993, 74 (04) : 597 - 608
[8] The first α helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins bid and PUMA
Cartron, PF
Gallenne, T
Bougras, G
Gautier, F
Manero, F
Vusio, P
Meflah, K
Vallette, FM
Juin, P
[J]. MOLECULAR CELL, 2004, 16 (05) : 807 - 818
[9] Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Certo, Michael
Moore, Victoria Del Gaizo
Nishino, Mari
Wei, Guo
Korsmeyer, Stanley
Armstrong, Scott A.
Letai, Anthony
[J]. CANCER CELL, 2006, 9 (05) : 351 - 365
[10] Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma
Chanan-Khan, Asher A.
Niesvizky, Ruben
Hohl, Raymond J.
Zimmerman, Todd M.
Christiansen, Neal P.
Schiller, Gary J.
Callander, Natalie
Lister, John
Oken, Martin
Jagannath, Sundar
[J]. LEUKEMIA & LYMPHOMA, 2009, 50 (04) : 559 - 565

← 1 2 3 4 5 6 7 8 →